Connections in pharmacology: Innovation serving translational medicine

Drug Discovery Today

Volumn 19, Issue 7, 2014, Pages 820-823

  Montero Melendez, Trinidad ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LIPOCORTIN 1; PARTHENOLIDE; PHOSPHOTRANSFERASE INHIBITOR; PROSTAGLANDIN; SHORT HAIRPIN RNA; TOPIRAMATE; TRINITROBENZENESULFONIC ACID; VORINOSTAT; TRANSCRIPTOME;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIINFLAMMATORY ACTIVITY; CLINICAL PHARMACOLOGY; COLITIS; COST EFFECTIVENESS ANALYSIS; DOWN REGULATION; DRUG DEVELOPMENT; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG MECHANISM; DRUG REPOSITIONING; ENTERITIS; FEEDBACK SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC ASSOCIATION; GENOME; HUMAN; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; META ANALYSIS (TOPIC); PERSONALIZED MEDICINE; REVIEW; STOMACH CANCER; TRANSLATIONAL RESEARCH; TREATMENT DURATION; UPREGULATION; ANIMAL; PROCEDURES; TRENDS;

ANIMALS; DRUG DISCOVERY; DRUG REPOSITIONING; HUMANS; TRANSCRIPTOME; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84903756591     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.11.022     Document Type: Short Survey

References (33)

1. K.I. Kaitin Deconstructing the drug development process: the new face of innovation Clin. Pharmacol. Ther. 87 2010 356 361
2. K.I. Kaitin The landscape for pharmaceutical innovation: drivers of cost-effective clinical research Pharm. Outsourcing 2010 2010 3605
3. C.P. Milne, and K.I. Kaitin Translational medicine: an engine of change for bringing new technology to community health Sci. Transl. Med. 1 2009 5cm5
4. J. Loscalzo et al. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology Mol. Syst. Biol. 3 2007 124
5. A.A. Alizadeh et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511 (Pubitemid 30082188)
6. A.D. Roses Pharmacogenetics and drug development: the path to safer and more effective drugs Nat. Rev. Genet. 5 2004 645 656 (Pubitemid 39150121)
7. J.T. Dudley et al. Drug discovery in a multidimensional world: systems, patterns, and networks J. Cardiovasc. Transl. Res. 3 2010 438 447
8. F. Al-Shahrour et al. From genes to functional classes in the study of biological systems BMC Bioinformatics 8 2007 114
9. A.R. Joyce, and B.O. Palsson The model organism as a system: integrating 'omics' data sets Nat. Rev. Mol. Cell Biol. 7 2006 198 210
10. J. Lamb et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935 (Pubitemid 44497995)
11. J. Lamb The Connectivity Map: a new tool for biomedical research Nat. Rev. Cancer 7 2007 54 60 (Pubitemid 46020847)
12. S.R. Gullans Connecting the dots using gene-expression profiles N. Engl. J. Med. 355 2006 2042 2044 (Pubitemid 44708025)
13. Y.A. Lussier, and J.L. Chen The emergence of genome-based drug repositioning Sci. Transl. Med. 3 2011 96ps35
14. M. Sirota et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data Sci. Transl. Med. 3 2011 96ra77
15. J.T. Dudley et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease Sci. Transl. Med. 3 2011 96ra76
16. S. Claerhout et al. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer PLoS ONE 6 2011 e24662
17. D.C. Hassane et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data Blood 111 2008 5654 5662
18. Y. Zhong et al. Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase J. Am. Soc. Nephrol. 24 2013 801 811
19. M. Zimmer et al. The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2 Cancer Res. 70 2010 3071 3079
20. H. Hieronymus et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators Cancer Cell 10 2006 321 330 (Pubitemid 44512193)
21. Z. Wen et al. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map PLoS ONE 6 2011 e18278
22. D. Renshaw et al. Downstream gene activation of the receptor ALX by the agonist annexin A1 PLoS ONE 5 2010 e12771
23. T. Montero-Melendez et al. Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors Cell Death Differ. 20 2013 567 575
24. M. Iskar et al. Drug-induced regulation of target expression PLoS Comput. Biol. 6 2010 e1000925
25. F. Iorio et al. Discovery of drug mode of action and drug repositioning from transcriptional responses Proc. Natl. Acad. Sci. U. S. A. 107 2010 14621 14626
26. C. Pacini et al. DvD: an R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data Bioinformatics 29 2013 132 134
27. P.M. Woollard et al. The application of next-generation sequencing technologies to drug discovery and development Drug Discov. Today 16 2011 512 519
28. J.P. Ioannidis et al. Repeatability of published microarray gene expression analyses Nat. Genet. 41 2009 149 155
29. A.A. Alsheikh-Ali et al. Public availability of published research data in high-impact journals PLoS ONE 6 2011 e24357
30. N.S. Young et al. Why current publication practices may distort science PLoS Med. 5 2008 e201
31. J.P. Ioannidis Why most published research findings are false PLoS Med. 2 2005 e124
32. A. Brazma et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat. Genet. 29 2001 365 371 (Pubitemid 34326681)
33. J. Rung, and A. Brazma Reuse of public genome-wide gene expression data Nat. Rev. Genet. 14 2013 89 99